Found 567 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies NA This clinical trial examines sustained oral fiber supplementation for patie...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer NA This clinical trial studies fludarabine phosphate, low-dose total body irra...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) PHASE1 This open-label Phase I study is designed to determine the maximum tolerate...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Study to Assess an Interphase Cycle With Flotetuzumab. PHASE2 Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Show More Location
NL-Amsterdam-VUMC
Learn More & Join Trial
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors PHASE1 This clinical study is to investigate the safety and tolerability of CAR mo...
Show More Location
Shanghai Zhongshan Hospital
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis PHASE1 One of the possible options for the treatment of MS at present is a high-do...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant PHASE1 This phase I trial studies the best dose and how well bendamustine works wi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial